FE65 as a link between VLDLR and APP to regulate their trafficking and processing

Molecular Neurodegeneration

Volumn 7, Issue 1, 2012, Pages

  Dumanis, Sonya B ^a   Chamberlain, Kelly A ^a   Jin Sohn, Yoo ^a   Jin Lee, Young ^a   Guénette, Suzanne Y ^g   Suzuki, Toshiharu ^b   Mathews, Paul M ^c   Pak, Daniel T S ^a   Rebeck, G William ^a   Suh, Yoo Hun ^d,e   Park, Hee Sae ^f   Hoe, Hyang Sook ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d Seoul National University   (South Korea)

^e Chonnam National University   (South Korea)

^f HARVARD MEDICAL SCHOOL   (United States)

^g NONE

Author keywords

APP trafficking; FE65; VLDLR

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GLUTATHIONE TRANSFERASE; PROTEIN FE65; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; APBB1 PROTEIN, RAT; LOW DENSITY LIPOPROTEIN RECEPTOR; NERVE PROTEIN; NUCLEAR PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CELL STRAIN COS7; CELL SURFACE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEOMICS; ANIMAL; BRAIN; CELL STRAIN COS1; CERCOPITHECUS; GENETIC TRANSFECTION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PROTEIN TRANSPORT; RAT; SPRAGUE DAWLEY RAT;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CERCOPITHECUS AETHIOPS; COS CELLS; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; TRANSFECTION;

EID: 84858300270     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-7-9     Document Type: Article

References (49)

1. Kesavapany S, Banner SJ, Lau KF, Shaw CE, Miller CC, Cooper JD, McLoughlin DM: Expression of the Fe65 adapter protein in adult and developing mouse brain. Neuroscience 2002, 115:951-960. (Pubitemid 35336035)
2. Cao X, Sudhof TC: A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001, 293:115-120. (Pubitemid 32625507)
3. Cao X, Sudhof TC: Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem 2004, 279:24601-24611. (Pubitemid 38725327)
4. Zhao Q, Lee FS: The transcriptional activity of the APP intracellular domain-Fe65 complex is inhibited by activation of the NF-kappaB pathway. Biochemistry 2003, 42:3627-3634. (Pubitemid 36368656)
5. Li Q, Sudhof TC: Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. J Biol Chem 2004, 279:10542-10550. (Pubitemid 38372665)
6. Ha TY, Chang KA, Kim J, Kim HS, Kim S, Chong YH, Suh YH: S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice. AD animal model PLoS One 2010, 5:e8840.
7. Kim HS, Kim EM, Lee JP, Park CH, Kim S, Seo JH, Chang KA, Yu E, Jeong SJ, Chong YH, Suh YH: C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J 2003, 17:1951-1953.
8. Xu Y, Kim HS, Joo Y, Choi Y, Chang KA, Park CH, Shin KY, Kim S, Cheon YH, Baik TK, Kim JH, Suh YH: Intracellular domains of amyloid precursor-like protein 2 interact with CP2 transcription factor in the nucleus and induce glycogen synthase kinase-3beta expression. Cell Death Differ 2007, 14:79-91. (Pubitemid 44911897)
9. Ermekova KS, Zambrano N, Linn H, Minopoli G, Gertler F, Russo T, Sudol M: The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophila enabled. J Biol Chem 1997, 272:32869-32877. (Pubitemid 28023623)
10. Sabo SL, Ikin AF, Buxbaum JD, Greengard P: The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J Cell Biol 2001, 153:1403-1414. (Pubitemid 34286125)
11. Guenette S, Chang Y, Hiesberger T, Richardson JA, Eckman CB, Eckman EA, Hammer RE, Herz J: Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. EMBO J 2006, 25:420-431. (Pubitemid 43152862)
12. Borg JP, Ooi J, Levy E, Margolis B: The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 1996, 16:6229-6241. (Pubitemid 26360983)
13. Guenette SY, Chen J, Ferland A, Haass C, Capell A, Tanzi RE: hFE65L influences amyloid precursor protein maturation and secretion. J Neurochem 1999, 73:985-993. (Pubitemid 29395454)
14. Santiard-Baron D, Langui D, Delehedde M, Delatour B, Schombert B, Touchet N, Tremp G, Paul MF, Blanchard V, Sergeant N, Delacourte A, Duyckaerts C, Pradier L, Mercken L: Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load. J Neurochem 2005, 93:330-338. (Pubitemid 40547490)
15. Santiard-Baron D, Langui D, Delehedde M, Delatour B, Schombert B, Touchet N, Tremp G, Paul MF, Blanchard V, Sergeant N, Delacourte A, Duyckaerts C, Pradier L, Mercken L: Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load. J Neurochem 2005, 93:330-338. (Pubitemid 40547490)
16. Sabo SL, Lanier LM, Ikin AF, Khorkova O, Sahasrabudhe S, Greengard P, Buxbaum JD: Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J Biol Chem 1999, 274:7952-7957.
17. Hoe HS, Magill LA, Guenette S, Fu Z, Vicini S, Rebeck GW: FE65 interaction with the ApoE receptor ApoEr2. J Biol Chem 2006, 281:24521-24530. (Pubitemid 44274227)
18. Pietrzik CU, Busse T, Merriam DE, Weggen S, Koo EH: The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J 2002, 21:5691-5700. (Pubitemid 35315269)
19. Trommsdorff M, Borg JP, Margolis B, Herz J: Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem 1998, 273:33556-33560. (Pubitemid 29005740)
20. Pietrzik CU, Yoon IS, Jaeger S, Busse T, Weggen S, Koo EH: FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci 2004, 24:4259-4265. (Pubitemid 38620802)
21. Mulvihill MM, Guttman M, Komives EA: Protein Interactions among Fe65, the Low-Density Lipoprotein Receptor-Related Protein, and the Amyloid Precursor Protein. Biochemistry 2011, 50:6208-6216.
22. Hoe HS, Rebeck GW: Regulation of ApoE receptor proteolysis by ligand binding. Brain Res Mol Brain Res 2005, 137:31-39.
23. Kinoshita A, Shah T, Tangredi MM, Strickland DK, Hyman BT: The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J Biol Chem 2003, 278:41182-41188. (Pubitemid 37280944)
24. Gao Y, Pimplikar SW: The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc Natl Acad Sci USA 2001, 98:14979-14984. (Pubitemid 34013955)
25. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, Hyman BT, Strickland DK: LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 1995, 82:331-340.
26. Hong C, Duit S, Jalonen P, Out R, Scheer L, Sorrentino V, Boyadjian R, Rodenburg KW, Foley E, Korhonen L, Lindholm D, Nimpf J, van Berkel TJ, Tontonoz P, Zelcer N: The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J Biol Chem 2010, 25:19720-6.
27. McLoughlin DM, Miller CC: The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system. FEBS Lett 1996, 397:197-200. (Pubitemid 26414016)
28. Bressler SL, Gray MD, Sopher BL, Hu Q, Hearn MG, Pham DG, Dinulos MB, Fukuchi K, Sisodia SS, Miller MA, Disteche CM, Martin GM: cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum Mol Genet 1996, 5:1589-1598. (Pubitemid 26328875)
29. Minopoli G, de Candia P, Bonetti A, Faraonio R, Zambrano N, Russo T: The beta-amyloid precursor protein functions as a cytosolic anchoring site that prevents Fe65 nuclear translocation. J Biol Chem 2001, 276:6545-6550. (Pubitemid 37373518)
30. Kinoshita A, Whelan CM, Smith CJ, Berezovska O, Hyman BT: Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J Neurochem 2002, 82:839-847.
31. Cam JA, Zerbinatti CV, Knisely JM, Hecimovic S, Li Y, Bu G: The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production. J Biol Chem 2004, 279:29639-29646. (Pubitemid 38915847)
32. Zerbinatti CV, Wozniak DF, Cirrito J, Cam JA, Osaka H, Bales KR, Zhuo M, Paul SM, Holtzman DM, Bu G: Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 2004, 101:1075-1080. (Pubitemid 38160586)
33. Cam JA, Zerbinatti CV, Li Y, Bu G: Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein. J Biol Chem 2005, 280:15464-15470. (Pubitemid 40562905)
34. Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, Strickland DK: Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem 2000, 275:7410-7415. (Pubitemid 30146296)
35. Fuentealba RA, Barria MI, Lee J, Cam J, Araya C, Escudero CA, Inestrosa NC, Bronfman FC, Bu G, Marzolo MP: ApoER2 expression increases Abeta production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts andin the regulation of gamma-secretase activity. Mol Neurodegener 2007, 2:14.
36. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, Chen F, Shibata N, Lunetta KL, Pardossi-Piquard R, Bohm C, Wakutani Y, Cupples LA, Cuenco KT, Green RC, Pinessi L, Rainero I, Sorbi S, Bruni A, Duara R, Friedland RP, Inzelberg R, Hampe W, Bujo H, Song YQ, Andersen OM, Willnow TE, Graff-Radford N, Petersen RC, Dickson D, Der SD, Fraser PE, Schmitt-Ulms G, Younkin S, Mayeux R, Farrer LA, St George-Hyslop P: The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007, 39:168-177. (Pubitemid 46184347)
37. Ranganathan S, Noyes NC, Migliorini M, Winkles JA, Battey FD, Hyman BT, Smith E, Yepes M, Mikhailenko I, Strickland DK: LRAD3, A Novel Low-Density Lipoprotein Receptor Family Member That Modulates Amyloid Precursor Protein Trafficking. J Neurosci 2011, 31:10836-10846.
38. Koo EH, Squazzo SL: Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 1994, 269:17386-17389. (Pubitemid 24218009)
39. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ, Chen X, Stokin GB, Koo EH: Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem 1999, 274:18851-18856.
40. D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T: Reelin is a ligand for lipoprotein receptors. Neuron 1999, 24:471-479. (Pubitemid 29508420)
41. Weiss KH, Johanssen C, Tielsch A, Herz J, Deller T, Frotscher M, Forster E: Malformation of the radial glial scaffold in the dentate gyrus of reeler mice, scrambler mice, and ApoER2/VLDLR-deficient mice. J Comp Neurol 2003, 460:56-65. (Pubitemid 36438277)
42. Hua J, Guerin KI, Chen J, Michan S, Stahl A, Krah NM, Seaward MR, Dennison RJ, Juan AM, Hatton CJ, Sapieha P, Sinclair DA, Smith LE: Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice. Invest Ophthalmol Vis Sci 2011, 52:2809-2816.
43. Wang Y, Zhang M, Moon C, Hu Q, Wang B, Martin G, Sun Z, Wang H: The APP-interacting protein FE65 is required for hippocampus-dependent learning and long-term potentiation. Learn Mem 2009, 16:537-544.
44. Muller U, Cristina N, Li ZW, Wolfer DP, Lipp HP, Rulicke T, Brandner S, Aguzzi A, Weissmann C: Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene. Cell 1994, 79:755-765.
45. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J: Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 2002, 277:39944-39952. (Pubitemid 35190981)
46. Senechal Y, Kelly PH, Dev KK: Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning. Behav Brain Res 2008, 186:126-132. (Pubitemid 350100902)
47. Weyer SW, Klevanski M, Delekate A, Voikar V, Aydin D, Hick M, Filippov M, Drost N, Schaller KL, Saar M, Vogt MA, Gass P, Samanta A, Jaschke A, Korte M, Wolfer DP, Caldwell JH, Muller UC: APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J 2011, 30:2266-2280.
48. Dumanis SB, Cha HJ, Song JM, Trotter JH, Spitzer M, Lee JY, Weeber EJ, Turner RS, Pak DT, Rebeck GW, Hoe HS: ApoE receptor 2 regulates synapse and dendritic spine formation. PLoS One 2011, 6:e17203.
49. Lee KJ, Moussa CE, Lee Y, Sung Y, Howell BW, Turner RS, Pak DT, Hoe HS: Beta amyloid-independent role of amyloid precursor protein in generation and maintenance of dendritic spines. Neuroscience 2010, 169:344-356.